{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:50:05Z","timestamp":1794588605351,"version":"4.9.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T00:00:00Z","timestamp":1534723200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1038\/s41591-018-0139-y","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T08:59:42Z","timestamp":1533805182000},"page":"1568-1578","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":203,"title":["Genetically engineered human cortical spheroid models of tuberous sclerosis"],"prefix":"10.1038","volume":"24","author":[{"given":"John D.","family":"Blair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Hockemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0135-0972","authenticated-orcid":false,"given":"Helen S.","family":"Bateup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,20]]},"reference":[{"key":"139_CR1","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1126\/science.277.5327.805","volume":"277","author":"M Slegtenhorst van","year":"1997","unstructured":"van Slegtenhorst, M. et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 277, 805\u2013808 (1997).","journal-title":"Science"},{"key":"139_CR2","doi-asserted-by":"crossref","unstructured":"European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 75, 1305\u20131315 (1993).","DOI":"10.1016\/0092-8674(93)90618-Z"},{"key":"139_CR3","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMra055323","volume":"355","author":"PB Crino","year":"2006","unstructured":"Crino, P. B., Nathanson, K. L. & Henske, E. P. The tuberous sclerosis complex. N. Engl. J. Med. 355, 1345\u20131356 (2006).","journal-title":"N. Engl. J. Med."},{"issue":"Suppl 1","key":"139_CR4","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1528-1167.2009.02458.x","volume":"51","author":"EA Thiele","year":"2010","unstructured":"Thiele, E. A. Managing and understanding epilepsy in tuberous sclerosis complex. Epilepsia 51(Suppl 1), 90\u201391 (2010).","journal-title":"Epilepsia"},{"key":"139_CR5","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S1474-4422(15)00069-1","volume":"14","author":"P Curatolo","year":"2015","unstructured":"Curatolo, P., Moavero, R. & de Vries, P. J. Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol. 14, 733\u2013745 (2015).","journal-title":"Lancet Neurol."},{"key":"139_CR6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00401-013-1085-x","volume":"125","author":"PB Crino","year":"2013","unstructured":"Crino, P. B. Evolving neurobiology of tuberous sclerosis complex. Acta Neuropathol. 125, 317\u2013332 (2013).","journal-title":"Acta Neuropathol."},{"key":"139_CR7","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1212\/WNL.0b013e3182768923","volume":"79","author":"AR Mohamed","year":"2012","unstructured":"Mohamed, A. R. et al. Intrinsic epileptogenicity of cortical tubers revealed by intracranial EEG monitoring. Neurology 79, 2249\u20132257 (2012).","journal-title":"Neurology"},{"key":"139_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40478-015-0191-5","volume":"3","author":"AA Sosunov","year":"2015","unstructured":"Sosunov, A. A. et al. Epileptogenic but MRI-normal perituberal tissue in Tuberous Sclerosis Complex contains tuber-specific abnormalities. Acta Neuropathol. Commun. 3, 17 (2015).","journal-title":"Acta Neuropathol. Commun."},{"key":"139_CR9","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1212\/01.wnl.0000280579.04974.c0","volume":"70","author":"FE Jansen","year":"2008","unstructured":"Jansen, F. E. et al. Cognitive impairment in tuberous sclerosis complex is a multifactorial condition. Neurology 70, 916\u2013923 (2008).","journal-title":"Neurology"},{"key":"139_CR10","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.stem.2011.09.008","volume":"9","author":"L Magri","year":"2011","unstructured":"Magri, L. et al. Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions. Cell Stem Cell. 9, 447\u2013462 (2011).","journal-title":"Cell Stem Cell."},{"key":"139_CR11","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1172\/JCI44909","volume":"121","author":"DM Feliciano","year":"2011","unstructured":"Feliciano, D. M., Su, T., Lopez, J., Platel, J. C. & Bordey, A. Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice. J. Clin. Invest. 121, 1596\u20131607 (2011).","journal-title":"J. Clin. Invest."},{"key":"139_CR12","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1093\/hmg\/ddp025","volume":"18","author":"SW Way","year":"2009","unstructured":"Way, S. W. et al. Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse. Hum. Mol. Genet. 18, 1252\u20131265 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"139_CR13","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1006\/mcne.2002.1184","volume":"21","author":"H Onda","year":"2002","unstructured":"Onda, H. et al. Tsc2 null murine neuroepithelial cells are a model for human tuber giant cells, and show activation of an mTOR pathway. Mol. Cell. Neurosci. 21, 561\u2013574 (2002).","journal-title":"Mol. Cell. Neurosci."},{"key":"139_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.nbd.2011.08.024","volume":"45","author":"RP Carson","year":"2012","unstructured":"Carson, R. P., Van Nielen, D. L., Winzenburger, P. A. & Ess, K. C. Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin. Neurobiol. Dis. 45, 369\u2013380 (2012).","journal-title":"Neurobiol. Dis."},{"key":"139_CR15","doi-asserted-by":"publisher","first-page":"E1070","DOI":"10.1073\/pnas.1106454108","volume":"108","author":"J Goto","year":"2011","unstructured":"Goto, J. et al. Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex. Proc. Natl Acad. Sci. USA 108, E1070\u20131079 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"139_CR16","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.1523\/JNEUROSCI.5540-06.2007","volume":"27","author":"L Meikle","year":"2007","unstructured":"Meikle, L. et al. A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival. J. Neurosci. 27, 5546\u20135558 (2007).","journal-title":"J. Neurosci."},{"key":"139_CR17","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/hmg\/ddq491","volume":"20","author":"LH Zeng","year":"2011","unstructured":"Zeng, L. H. et al. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex. Hum. Mol. Genet. 20, 445\u2013454 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"139_CR18","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.neuron.2015.12.008","volume":"89","author":"JC Silbereis","year":"2016","unstructured":"Silbereis, J. C., Pochareddy, S., Zhu, Y., Li, M. & Sestan, N. The cellular and molecular landscapes of the developing human central nervous system. Neuron 89, 248\u2013268 (2016).","journal-title":"Neuron"},{"key":"139_CR19","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nrn2097","volume":"8","author":"C Dehay","year":"2007","unstructured":"Dehay, C. & Kennedy, H. Cell-cycle control and cortical development. Nat. Rev. Neurosci. 8, 438\u2013450 (2007).","journal-title":"Nat. Rev. Neurosci."},{"key":"139_CR20","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1242\/dev.090571","volume":"141","author":"M Florio","year":"2014","unstructured":"Florio, M. & Huttner, W. B. Neural progenitors, neurogenesis and the evolution of the neocortex. Development 141, 2182\u20132194 (2014).","journal-title":"Development"},{"key":"139_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cell.2011.06.030","volume":"146","author":"JH Lui","year":"2011","unstructured":"Lui, J. H., Hansen, D. V. & Kriegstein, A. R. Development and evolution of the human neocortex. Cell 146, 18\u201336 (2011).","journal-title":"Cell"},{"key":"139_CR22","doi-asserted-by":"publisher","first-page":"13571","DOI":"10.1073\/pnas.202476899","volume":"99","author":"AR Tee","year":"2002","unstructured":"Tee, A. R. et al. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc. Natl Acad. Sci. USA 99, 13571\u201313576 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"139_CR23","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism, and disease. Cell 168, 960\u2013976 (2017).","journal-title":"Cell"},{"key":"139_CR24","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrm2672","volume":"10","author":"XM Ma","year":"2009","unstructured":"Ma, X. M. & Blenis, J. Molecular mechanisms of mTOR-mediated translational control. Nat. Rev. Mol. Cell Biol. 10, 307\u2013318 (2009).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"139_CR25","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1101\/gad.1110003","volume":"17","author":"K Inoki","year":"2003","unstructured":"Inoki, K., Li, Y., Xu, T. & Guan, K. L. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 17, 1829\u20131834 (2003).","journal-title":"Genes Dev."},{"key":"139_CR26","doi-asserted-by":"publisher","first-page":"8313","DOI":"10.1074\/jbc.C500451200","volume":"281","author":"H Chong-Kopera","year":"2006","unstructured":"Chong-Kopera, H. et al. TSC1 stabilizes TSC2 by inhibiting the interaction between TSC2 and the HERC1 ubiquitin ligase. J. Biol. Chem. 281, 8313\u20138316 (2006).","journal-title":"J. Biol. Chem."},{"key":"139_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1042\/BJ20080281","volume":"412","author":"J Huang","year":"2008","unstructured":"Huang, J. & Manning, B. D. The TSC1\u2013TSC2 complex: a molecular switchboard controlling cell growth. Biochem J. 412, 179\u2013190 (2008).","journal-title":"Biochem J."},{"key":"139_CR28","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrneurol.2016.81","volume":"12","author":"PB Crino","year":"2016","unstructured":"Crino, P. B. The mTOR signalling cascade: paving new roads to cure neurological disease. Nat. Rev. Neurol. 12, 379\u2013392 (2016).","journal-title":"Nat. Rev. Neurol."},{"key":"139_CR29","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1007\/s00018-012-1196-x","volume":"70","author":"L Magri","year":"2013","unstructured":"Magri, L. & Galli, R. mTOR signaling in neural stem cells: from basic biology to disease. Cell. Mol. Life Sci. 70, 2887\u20132898 (2013).","journal-title":"Cell. Mol. Life Sci."},{"key":"139_CR30","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1086\/302648","volume":"65","author":"KS Au","year":"1999","unstructured":"Au, K. S., Hebert, A. A., Roach, E. S. & Northrup, H. Complete inactivation of the TSC2 gene leads to formation of hamartomas. Am. J. Hum. Genet. 65, 1790\u20131795 (1999).","journal-title":"Am. J. Hum. Genet."},{"key":"139_CR31","first-page":"400","volume":"59","author":"EP Henske","year":"1996","unstructured":"Henske, E. P. et al. Allelic loss is frequent in tuberous sclerosis kidney lesions but rare in brain lesions. Am. J. Hum. Genet. 59, 400\u2013406 (1996).","journal-title":"Am. J. Hum. Genet."},{"key":"139_CR32","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1086\/301804","volume":"62","author":"TA Smolarek","year":"1998","unstructured":"Smolarek, T. A. et al. Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis. Am. J. Hum. Genet. 62, 810\u2013815 (1998).","journal-title":"Am. J. Hum. Genet."},{"key":"139_CR33","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1136\/jmg.33.11.962","volume":"33","author":"T Sepp","year":"1996","unstructured":"Sepp, T., Yates, J. R. & Green, A. J. Loss of heterozygosity in tuberous sclerosis hamartomas. J. Med. Genet. 33, 962\u2013964 (1996).","journal-title":"J. Med. Genet."},{"key":"139_CR34","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1093\/jnen\/63.12.1236","volume":"63","author":"JA Chan","year":"2004","unstructured":"Chan, J. A. et al. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation. J. Neuropathol. Exp. Neurol. 63, 1236\u20131242 (2004).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"139_CR35","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1212\/WNL.0b013e3181e04325","volume":"74","author":"PB Crino","year":"2010","unstructured":"Crino, P. B., Aronica, E., Baltuch, G. & Nathanson, K. L. Biallelic TSC gene inactivation in tuberous sclerosis complex. Neurology 74, 1716\u20131723 (2010).","journal-title":"Neurology"},{"key":"139_CR36","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/j.1750-3639.2010.00416.x","volume":"20","author":"W Qin","year":"2010","unstructured":"Qin, W. et al. Analysis of TSC cortical tubers by deep sequencing of TSC1, TSC2 and KRAS demonstrates that small second-hit mutations in these genes are rare events. Brain Pathol. 20, 1096\u20131105 (2010).","journal-title":"Brain Pathol."},{"key":"139_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15816","volume":"8","author":"KR Martin","year":"2017","unstructured":"Martin, K. R. et al. The genomic landscape of tuberous sclerosis complex. Nat. Commun. 8, 15816 (2017).","journal-title":"Nat. Commun."},{"key":"139_CR38","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.molmed.2007.06.003","volume":"13","author":"PJ Vries de","year":"2007","unstructured":"de Vries, P. J. & Howe, C. J. The tuberous sclerosis complex proteins\u2014a GRIPP on cognition and neurodevelopment. Trends Mol. Med. 13, 319\u2013326 (2007).","journal-title":"Trends Mol. Med."},{"key":"139_CR39","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.celrep.2017.10.095","volume":"21","author":"JD Blair","year":"2017","unstructured":"Blair, J. D., Hockemeyer, D., Doudna, J. A., Bateup, H. S. & Floor, S. N. Widespread translational remodeling during human neuronal differentiation. Cell Rep. 21, 2005\u20132016 (2017).","journal-title":"Cell Rep."},{"key":"139_CR40","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature11083","volume":"485","author":"CC Thoreen","year":"2012","unstructured":"Thoreen, C. C. et al. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 485, 109\u2013113 (2012).","journal-title":"Nature"},{"key":"139_CR41","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","volume":"169","author":"BD Manning","year":"2017","unstructured":"Manning, B. D. & Toker, A. AKT\/PKB signaling: navigating the network. Cell 169, 381\u2013405 (2017).","journal-title":"Cell"},{"key":"139_CR42","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nbt.1529","volume":"27","author":"SM Chambers","year":"2009","unstructured":"Chambers, S. M. et al. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat. Biotechnol. 27, 275\u2013280 (2009).","journal-title":"Nat. Biotechnol."},{"key":"139_CR43","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.3415","volume":"12","author":"AM Pa\u015fca","year":"2015","unstructured":"Pa\u015fca, A. M. et al. Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nat. Methods 12, 671\u2013678 (2015).","journal-title":"Nat. Methods"},{"key":"139_CR44","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2012.06.009","volume":"47","author":"CC Dibble","year":"2012","unstructured":"Dibble, C. C. et al. TBC1D7 is a third subunit of the TSC1\u2013TSC2 complex upstream of mTORC1. Mol. Cell 47, 535\u2013546 (2012).","journal-title":"Mol. Cell"},{"key":"139_CR45","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.neuron.2007.04.019","volume":"54","author":"FD Miller","year":"2007","unstructured":"Miller, F. D. & Gauthier, A. S. Timing is everything: making neurons versus glia in the developing cortex. Neuron 54, 357\u2013369 (2007).","journal-title":"Neuron"},{"key":"139_CR46","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1126\/science.278.5337.477","volume":"278","author":"A Bonni","year":"1997","unstructured":"Bonni, A. et al. Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science 278, 477\u2013483 (1997).","journal-title":"Science"},{"key":"139_CR47","doi-asserted-by":"publisher","first-page":"7799","DOI":"10.1523\/JNEUROSCI.3294-12.2013","volume":"33","author":"D Clo\u00ebtta","year":"2013","unstructured":"Clo\u00ebtta, D. et al. Inactivation of mTORC1 in the developing brain causes microcephaly and affects gliogenesis. J. Neurosci. 33, 7799\u20137810 (2013).","journal-title":"J. Neurosci."},{"key":"139_CR48","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/GIM.0b013e31803068c7","volume":"9","author":"KS Au","year":"2007","unstructured":"Au, K. S. et al. Genotype\/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet. Med. 9, 88\u2013100 (2007).","journal-title":"Genet. Med."},{"key":"139_CR49","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/nbt.1562","volume":"27","author":"D Hockemeyer","year":"2009","unstructured":"Hockemeyer, D. et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat. Biotechnol. 27, 851\u2013857 (2009).","journal-title":"Nat. Biotechnol."},{"key":"139_CR50","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/S0387-7604(01)00304-7","volume":"23","author":"M Mizuguchi","year":"2001","unstructured":"Mizuguchi, M. & Takashima, S. Neuropathology of tuberous sclerosis. Brain Dev. 23, 508\u2013515 (2001).","journal-title":"Brain Dev."},{"issue":"Suppl 2","key":"139_CR51","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1528-1167.2008.01493.x","volume":"49","author":"AA Sosunov","year":"2008","unstructured":"Sosunov, A. A. et al. Tuberous sclerosis: a primary pathology of astrocytes? Epilepsia 49(Suppl 2), 53\u201362 (2008).","journal-title":"Epilepsia"},{"key":"139_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0347-3","volume":"8","author":"N Grabole","year":"2016","unstructured":"Grabole, N. et al. Genomic analysis of the molecular neuropathology of tuberous sclerosis using a human stem cell model. Genome Med. 8, 94 (2016).","journal-title":"Genome Med."},{"key":"139_CR53","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.celrep.2016.02.090","volume":"15","author":"V Costa","year":"2016","unstructured":"Costa, V. et al. mTORC1 inhibition corrects neurodevelopmental and synaptic alterations in a human stem cell model of tuberous sclerosis. Cell Rep. 15, 86\u201395 (2016).","journal-title":"Cell Rep."},{"key":"139_CR54","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.stemcr.2017.02.020","volume":"8","author":"Y Li","year":"2017","unstructured":"Li, Y. et al. Abnormal neural progenitor cells differentiated from induced pluripotent stem cells partially mimicked development of TSC2 neurological abnormalities. Stem Cell Rep 8, 883\u2013893 (2017).","journal-title":"Stem Cell Rep"},{"key":"139_CR55","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10519-012-9571-9","volume":"43","author":"PT Tsai","year":"2013","unstructured":"Tsai, P. T. et al. Prenatal rapamycin results in early and late behavioral abnormalities in wildtype C57BL\/6 mice. Behav. Genet. 43, 51\u201359 (2013).","journal-title":"Behav. Genet."},{"key":"139_CR56","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.eplepsyres.2007.10.002","volume":"78","author":"K Boer","year":"2008","unstructured":"Boer, K. et al. Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Epilepsy Res. 78, 7\u201321 (2008).","journal-title":"Epilepsy Res."},{"key":"139_CR57","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1016\/j.celrep.2017.11.106","volume":"21","author":"AM D\u2019Gama","year":"2017","unstructured":"D\u2019Gama, A. M. et al. Somatic mutations activating the mTOR pathway in dorsal telencephalic progenitors cause a continuum of cortical dysplasias. Cell Rep. 21, 3754\u20133766 (2017).","journal-title":"Cell Rep."},{"key":"139_CR58","doi-asserted-by":"publisher","first-page":"e1005637","DOI":"10.1371\/journal.pgen.1005637","volume":"11","author":"ME Tyburczy","year":"2015","unstructured":"Tyburczy, M. E. et al. Mosaic and intronic mutations in TSC1\/TSC2 explain the majority of TSC patients with no mutation identified by conventional testing. PLoS Genet. 11, e1005637 (2015).","journal-title":"PLoS Genet."},{"key":"139_CR59","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.cell.2010.04.010","volume":"141","author":"CJ Lengner","year":"2010","unstructured":"Lengner, C. J. et al. Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. Cell 141, 872\u2013883 (2010).","journal-title":"Cell"},{"key":"139_CR60","first-page":"e53583","volume":"108","author":"JD Blair","year":"2016","unstructured":"Blair, J. D., Bateup, H. S. & Hockemeyer, D. F. Establishment of genome-edited human pluripotent stem cell lines: from targeting to isolation. J. Vis. Exp 108, e53583 (2016).","journal-title":"J. Vis. Exp"},{"key":"139_CR61","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nprot.2013.019","volume":"8","author":"PK Mandal","year":"2013","unstructured":"Mandal, P. K. & Rossi, D. J. Reprogramming human fibroblasts to pluripotency using modified mRNA. Nat. Protoc. 8, 568\u2013582 (2013).","journal-title":"Nat. Protoc."},{"key":"139_CR62","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong, L. et al. Multiplex genome engineering using CRISPR\/Cas systems. Science 339, 819\u2013823 (2013).","journal-title":"Science"},{"key":"139_CR63","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nn.2467","volume":"13","author":"L Madisen","year":"2010","unstructured":"Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133\u2013140 (2010).","journal-title":"Nat. Neurosci."},{"key":"139_CR64","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.1232033","volume":"339","author":"P Mali","year":"2013","unstructured":"Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823\u2013826 (2013).","journal-title":"Science"},{"key":"139_CR65","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-1-61779-328-8_6","volume":"793","author":"SM Chambers","year":"2011","unstructured":"Chambers, S. M., Mica, Y., Studer, L. & Tomishima, M. J. Converting human pluripotent stem cells to neural tissue and neurons to model neurodegeneration. Methods Mol. Biol. 793, 87\u201397 (2011).","journal-title":"Methods Mol. Biol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41591-018-0139-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41591-018-0139-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41591-018-0139-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:56:55Z","timestamp":1684619815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-018-0139-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,20]]},"references-count":65,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["139"],"URL":"https:\/\/doi.org\/10.1038\/s41591-018-0139-y","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,20]]},"assertion":[{"value":"8 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}